
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial
Gholamreza Askari, Amirhossein Sahebkar, Davood Soleimani, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 43
Gholamreza Askari, Amirhossein Sahebkar, Davood Soleimani, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
Mangala Hegde, Sosmitha Girisa, Bandari BharathwajChetty, et al.
ACS Omega (2023) Vol. 8, Iss. 12, pp. 10713-10746
Open Access | Times Cited: 106
Mangala Hegde, Sosmitha Girisa, Bandari BharathwajChetty, et al.
ACS Omega (2023) Vol. 8, Iss. 12, pp. 10713-10746
Open Access | Times Cited: 106
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials
Ajaikumar B. Kunnumakkara, Mangala Hegde, Parama Dey, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 447-518
Open Access | Times Cited: 88
Ajaikumar B. Kunnumakkara, Mangala Hegde, Parama Dey, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 447-518
Open Access | Times Cited: 88
Curcumin‐piperine co‐supplementation and human health: A comprehensive review of preclinical and clinical studies
Hajar Heidari, Mohammad Bagherniya, Muhammed Majeed, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1462-1487
Open Access | Times Cited: 78
Hajar Heidari, Mohammad Bagherniya, Muhammed Majeed, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1462-1487
Open Access | Times Cited: 78
Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations
Yakubu Jibira, Amit V. Pandey
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 637-637
Open Access | Times Cited: 10
Yakubu Jibira, Amit V. Pandey
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 637-637
Open Access | Times Cited: 10
Curcumin for the treatment of COVID ‐19 patients: A meta‐analysis of randomized controlled trials
Arman Shafiee, Mohammad Mobin Teymouri Athar, Abia Shahid, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 3, pp. 1167-1175
Closed Access | Times Cited: 13
Arman Shafiee, Mohammad Mobin Teymouri Athar, Abia Shahid, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 3, pp. 1167-1175
Closed Access | Times Cited: 13
Ethnomedicinal, Phytochemistry and Antiviral Potential of Turmeric (Curcuma longa)
Bajarang Bal Lal Srivastava, Asha Ripanda, Hossein Miraji
Compounds (2022) Vol. 2, Iss. 3, pp. 200-221
Open Access | Times Cited: 21
Bajarang Bal Lal Srivastava, Asha Ripanda, Hossein Miraji
Compounds (2022) Vol. 2, Iss. 3, pp. 200-221
Open Access | Times Cited: 21
Promising clinical outcomes of nano‐curcumin treatment as an adjunct therapy in hospitalized COVID ‐19 patients: A randomized, double‐blinded, placebo‐controlled trial
Majid Sadeghizadeh, Elahe Asadollahi, Babak Jahangiri, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3631-3644
Closed Access | Times Cited: 12
Majid Sadeghizadeh, Elahe Asadollahi, Babak Jahangiri, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3631-3644
Closed Access | Times Cited: 12
Immunoregulatory effects of nanocurcumin in inflammatory milieu: Focus on COVID-19
Fahimeh Lavi Arab, Akram Hoseinzadeh, Fatemeh Mohammadi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116131-116131
Open Access | Times Cited: 4
Fahimeh Lavi Arab, Akram Hoseinzadeh, Fatemeh Mohammadi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116131-116131
Open Access | Times Cited: 4
The efficacy and safety of ginger (Zingiber officinale) rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial
Ali Ameri, Mehdi Farashahinejad, Parivash Davoodian, et al.
Medicine (2024) Vol. 103, Iss. 22, pp. e38289-e38289
Open Access | Times Cited: 3
Ali Ameri, Mehdi Farashahinejad, Parivash Davoodian, et al.
Medicine (2024) Vol. 103, Iss. 22, pp. e38289-e38289
Open Access | Times Cited: 3
Therapeutic potential of curcumin in ARDS and COVID ‐19
Madathilparambil V. Suresh, Sairah Francis, Sinan Aktay, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 4, pp. 267-276
Open Access | Times Cited: 15
Madathilparambil V. Suresh, Sairah Francis, Sinan Aktay, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 4, pp. 267-276
Open Access | Times Cited: 15
Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis
Ke Liu, Yi Zhu, X. L. Cao, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21648-e21648
Open Access | Times Cited: 7
Ke Liu, Yi Zhu, X. L. Cao, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21648-e21648
Open Access | Times Cited: 7
Curcumin as a natural potential drug candidate against important zoonotic viruses and prions: A narrative review
Setareh Azarkar, Masoud Abedi, Ali Sheikh Olya Lavasani, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 3080-3121
Closed Access | Times Cited: 2
Setareh Azarkar, Masoud Abedi, Ali Sheikh Olya Lavasani, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 3080-3121
Closed Access | Times Cited: 2
The effect of curcumin‐piperine supplementation on lipid profile, glycemic index, inflammation, and blood pressure in patients with type 2 diabetes mellitus and hypertriglyceridemia
Hanie Hosseini, Mohammad Bagherniya, Amirhossein Sahebkar, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 11, pp. 5150-5161
Closed Access | Times Cited: 2
Hanie Hosseini, Mohammad Bagherniya, Amirhossein Sahebkar, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 11, pp. 5150-5161
Closed Access | Times Cited: 2
Effective inhibition of HCoV-OC43 and SARS-CoV-2 by phytochemicals in vitro and in vivo
Durbadal Ojha, Forrest Jessop, Catharine M. Bosio, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 3, pp. 106893-106893
Open Access | Times Cited: 6
Durbadal Ojha, Forrest Jessop, Catharine M. Bosio, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 3, pp. 106893-106893
Open Access | Times Cited: 6
The Efficacy of Herbs as Complementary and Alternative Therapy in Recovery and Clinical Outcome Among People with COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression
Maria Komariah, Shakira Amirah, Sidik Maulana, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 611-627
Open Access | Times Cited: 6
Maria Komariah, Shakira Amirah, Sidik Maulana, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 611-627
Open Access | Times Cited: 6
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
A. M. Das, Swarnali Khan, Syamal Roy, et al.
(2023), pp. 336-376
Open Access | Times Cited: 6
A. M. Das, Swarnali Khan, Syamal Roy, et al.
(2023), pp. 336-376
Open Access | Times Cited: 6
Antiviral Mechanisms of Curcumin and Its Derivatives in Prevention and Treatment of COVID-19: A Review
Sahar Golpour-Hamedani, Makan Pourmasoumi, Gholamreza Askari, et al.
Advances in experimental medicine and biology (2023), pp. 397-411
Closed Access | Times Cited: 4
Sahar Golpour-Hamedani, Makan Pourmasoumi, Gholamreza Askari, et al.
Advances in experimental medicine and biology (2023), pp. 397-411
Closed Access | Times Cited: 4
Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial
Gholamreza Askari, Mohammad Bagherniya, Zahra Kiani, et al.
Advances in experimental medicine and biology (2023), pp. 413-426
Closed Access | Times Cited: 4
Gholamreza Askari, Mohammad Bagherniya, Zahra Kiani, et al.
Advances in experimental medicine and biology (2023), pp. 413-426
Closed Access | Times Cited: 4
Opportunities and Regulatory Challenges of Functional Foods and Nutraceuticals During COVID-19 Pandemic
Jobin Jose, Keyidaule Ndang, Madhusoodhana Ballakkuraya Chethana, et al.
Current Nutrition & Food Science (2024) Vol. 20, Iss. 10, pp. 1252-1271
Closed Access | Times Cited: 1
Jobin Jose, Keyidaule Ndang, Madhusoodhana Ballakkuraya Chethana, et al.
Current Nutrition & Food Science (2024) Vol. 20, Iss. 10, pp. 1252-1271
Closed Access | Times Cited: 1
Curcumin as a Promising Therapy for COVID-19: A Review
Arunava Kali, Marie Victor Pravin Charles
Global Journal of Medical Pharmaceutical and Biomedical Update (2024) Vol. 19, pp. 2-2
Closed Access | Times Cited: 1
Arunava Kali, Marie Victor Pravin Charles
Global Journal of Medical Pharmaceutical and Biomedical Update (2024) Vol. 19, pp. 2-2
Closed Access | Times Cited: 1
Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease
Jawaria Jabeen, Nabeel Ahmed, Zunaira Shahzad, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 510-540
Open Access | Times Cited: 1
Jawaria Jabeen, Nabeel Ahmed, Zunaira Shahzad, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 510-540
Open Access | Times Cited: 1
AMP kinase: A promising therapeutic drug target for post-COVID-19 complications
Mohammad Saquib Ashraf, Kanika Tuli, Shadman Moiz, et al.
Life Sciences (2024) Vol. 359, pp. 123202-123202
Closed Access | Times Cited: 1
Mohammad Saquib Ashraf, Kanika Tuli, Shadman Moiz, et al.
Life Sciences (2024) Vol. 359, pp. 123202-123202
Closed Access | Times Cited: 1
An outlook on the target‐based molecular mechanism of phytoconstituents as immunomodulators
Gazala Noor, Badruddeen Badruddeen, Juber Akhtar, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5058-5079
Open Access | Times Cited: 3
Gazala Noor, Badruddeen Badruddeen, Juber Akhtar, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5058-5079
Open Access | Times Cited: 3
COVID-19 and Nutrition: Focus on Chronic Kidney Disease
Denise Mafra, Julie Ann Kemp, L. Cardozo, et al.
Journal of Renal Nutrition (2023) Vol. 33, Iss. 6, pp. S118-S127
Closed Access | Times Cited: 2
Denise Mafra, Julie Ann Kemp, L. Cardozo, et al.
Journal of Renal Nutrition (2023) Vol. 33, Iss. 6, pp. S118-S127
Closed Access | Times Cited: 2